Clinical Research on Diabetic Complications

© 2022 by the authors; CC BY-NC-ND license

burnt-out diabetes; chronic kidney disease (CKD); dialysis; end-stage renal disease (ESRD); incident diabetes mellitus (DM); insulin resistance; dementia; dipeptidyl-peptidase IV inhibitors; diabetes mellitus; type 2; Alzheimer’s disease; dementia; vascular; diabetes; dementia; microperimetry; Alzheimer’s disease; type 2 diabetes mellitus; glucose fluctuations; sarcopenia; diabetic retinopathy; type 1 diabetes; quality of life; treatment satisfaction; patient-reported outcomes; type 1 diabetes; plaque characteristics; carotid plaque; echogenic plaque; diabetic foot syndrome; vascular disease; fibroblast growth factor 23; Klotho; inflammation; dermal electrochemical conductance; diabetes mellitus; neuropathy; primary care; screening; sudomotor reflex; prediabetes; arterial stiffness; baPWV; aspirin; primary prevention; diabetes mellitus; meta-analysis; trial sequential analysis; sCD36; type 1 diabetes mellitus; type 2 diabetes mellitus; branched-chain amino acids; metabolomics; NMR spectroscopy; type 2 diabetes mellitus; diabetes; diabetic kidney disease; reno-cardiovascular protection; sodium-glucose co-transporter 2 inhibitors; glucagon-like peptide-1 receptor agonists; dipeptidyl peptidase 4 inhibitors; diabetes; obesity; bariatric surgery; diabetic macroangiopathy; cardiovascular disease; heart disease; cerebrovascular disease; peripheral artery disease; diabetic foot disease; diabetic microangiopathy; diabetic retinopathy; diabetic kidney disease; diabetic neuropathy